Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis

Clin Infect Dis. 2000 Dec;31(6):1495-7. doi: 10.1086/317485.

Abstract

A review was conducted in Haiti to determine the timing and outcome of active tuberculosis (TB) in human immunodeficiency virus (HIV)-positive patients who had previously received isoniazid (INH) prophylaxis. Of 1005 HIV-seropositive patients who completed INH prophylaxis, 14 (1.4%) subsequently had active TB diagnosed. The median interval between discontinuation of INH prophylaxis and TB diagnosis was 8 months for 6 patients receiving 6 months of INH, 22 months for 5 patients receiving 12-24 months of INH, and 40 months for 3 patients receiving 24-36 months of INH (P = .026). There is a postprophylaxis effect on INH that is dependent upon the duration of therapy.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / prevention & control*
  • Adolescent
  • Adult
  • Antitubercular Agents / therapeutic use*
  • Haiti / epidemiology
  • Humans
  • Isoniazid / therapeutic use*
  • Retrospective Studies
  • Time Factors
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / epidemiology
  • Tuberculosis, Pulmonary / prevention & control*

Substances

  • Antitubercular Agents
  • Isoniazid